4.7 Review

Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy

Camilo de la Fuente-Sandoval et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study

L. M. Rowland et al.

MOLECULAR PSYCHIATRY (2016)

Article Clinical Neurology

Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam

Yijuan Du et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Article Psychology, Clinical

Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders

D. W. Volk et al.

PSYCHOLOGICAL MEDICINE (2016)

Article Psychiatry

In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients

W. Gordon Frankle et al.

AMERICAN JOURNAL OF PSYCHIATRY (2015)

Article Neuroimaging

GABA level, gamma oscillation, and working memory performance in schizophrenia

Chi-Ming A. Chen et al.

NEUROIMAGE-CLINICAL (2014)

Article Neuroimaging

GABA and glutamate in schizophrenia: A 7 T H-1-MRS study

Anouk Marsman et al.

NEUROIMAGE-CLINICAL (2014)

Article Clinical Neurology

Equipercentile linking of the BPRS and the PANSS

S. Leucht et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)

Article Clinical Neurology

GABA Predicts Inhibition of Frequency-Specific Oscillations in Schizophrenia

Laura M. Rowland et al.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2013)

Article Clinical Neurology

Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: The potential impact of GABA concentration in the visual cortex

Oguz Kelemen et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)

Article Psychiatry

In Vivo Measurements of Glutamate, GABA, and NAAG in Schizophrenia

Laura M. Rowland et al.

SCHIZOPHRENIA BULLETIN (2013)

Article Psychiatry

Deficits in Transcriptional Regulators of Cortical Parvalbumin Neurons in Schizophrenia

David W. Volk et al.

AMERICAN JOURNAL OF PSYCHIATRY (2012)

Review Neurosciences

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

David A. Lewis et al.

TRENDS IN NEUROSCIENCES (2012)

Review Clinical Neurology

Understanding aberrant white matter development in schizophrenia: an avenue for therapy?

Mark Walterfang et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)

Article Neurosciences

Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia

Dost Oenguer et al.

BIOLOGICAL PSYCHIATRY (2010)

Review Clinical Neurology

No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia

Naoki Goto et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)

Article Neurosciences

Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin

Christopher Paul Turner et al.

EXPERIMENTAL BRAIN RESEARCH (2010)

Article Psychiatry

Altered Markers of Tonic Inhibition in the Dorsolateral Prefrontal Cortex of Subjects With Schizophrenia

Jaime G. Maldonado-Aviles et al.

AMERICAN JOURNAL OF PSYCHIATRY (2009)

Review Health Care Sciences & Services

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)

Article Multidisciplinary Sciences

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

Vikaas S. Sohal et al.

NATURE (2009)

Article Neurosciences

Tiagabine Increases [11C] flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects

W. Gordon Frankle et al.

NEUROPSYCHOPHARMACOLOGY (2009)

Article Multidisciplinary Sciences

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

Francine M. Benes et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Clinical Neurology

Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia

Kelly A. Newell et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)

Article Biochemistry & Molecular Biology

Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo

AB Patel et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Neurosciences

Increased density of GABA(A) receptors in the superior temporal gyrus in schizophrenia

C Deng et al.

EXPERIMENTAL BRAIN RESEARCH (2006)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Article Biochemistry & Molecular Biology

Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis

G Battaglioli et al.

JOURNAL OF NEUROCHEMISTRY (2003)

Article Endocrinology & Metabolism

Imaging the GABA-benzodiazepine receptor subtype containing the α5-subunit in vivo with [11C]Ro15 4513 positron emission tomography

A Lingford-Hughes et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)

Article Multidisciplinary Sciences

Evolution of treatment effects over time: Empirical insight from recursive cumulative metaanalyses

JPA Ioannidis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Biochemistry & Molecular Biology

Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain

FM Benes et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2000)